Clinical Trial Update: Rubella Susceptibility in Multiparous Women

View source ↗

Summary

The clinical trial NCT00401505, sponsored by Unity Health Toronto, studying rubella susceptibility in multiparous women, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rubella

Snippet

Sponsor: Unity Health Toronto | Conditions: Rubella, Vaccine | Status: COMPLETED